STOCK TITAN

LevelJump to Acquire Two Alberta Diagnostic Imaging Clinics; Update on Year-End Reporting Documents

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
LevelJump Healthcare's subsidiary CTS has signed a definitive agreement to acquire two diagnostic imaging clinics in Calgary, Alberta for $1.92 million in cash. The IHFs provide x-ray, ultrasound, and mammography services, generating combined revenue of $2.2 million and EBITDA of $500,000. The acquisition, expected to close in July 2025, is subject to regulatory approval, due diligence, and securing institutional financing. Additionally, the company announced a delay in filing its 2024 year-end reporting documents, now expected within 7-10 days, after which it will seek to lift the current cease trade order and reinstate trading on TSX Venture Exchange.
La controllata di LevelJump Healthcare, CTS, ha firmato un accordo definitivo per acquisire due cliniche di diagnostica per immagini a Calgary, Alberta, per 1,92 milioni di dollari in contanti. Le strutture forniscono servizi di radiografia, ecografia e mammografia, generando un fatturato combinato di 2,2 milioni di dollari e un EBITDA di 500.000 dollari. L'acquisizione, che dovrebbe concludersi a luglio 2025, è soggetta all'approvazione regolamentare, alla due diligence e all'ottenimento di finanziamenti istituzionali. Inoltre, la società ha annunciato un ritardo nella presentazione dei documenti di rendicontazione di fine anno 2024, ora previsti entro 7-10 giorni, dopo i quali cercherà di revocare l'ordine di sospensione delle negoziazioni e di ripristinare la quotazione sulla TSX Venture Exchange.
La filial de LevelJump Healthcare, CTS, ha firmado un acuerdo definitivo para adquirir dos clínicas de diagnóstico por imagen en Calgary, Alberta, por 1,92 millones de dólares en efectivo. Las instalaciones proporcionan servicios de rayos X, ultrasonido y mamografía, generando ingresos combinados de 2,2 millones de dólares y un EBITDA de 500,000 dólares. La adquisición, que se espera cierre en julio de 2025, está sujeta a la aprobación regulatoria, la debida diligencia y la obtención de financiamiento institucional. Además, la compañía anunció un retraso en la presentación de sus documentos de reporte de fin de año 2024, ahora previstos dentro de 7-10 días, tras lo cual buscará levantar la orden de suspensión de comercio actual y restablecer la negociación en la TSX Venture Exchange.
LevelJump Healthcare의 자회사 CTS가 앨버타주 캘거리의 두 개 진단 영상 클리닉을 현금 192만 달러에 인수하는 최종 계약을 체결했습니다. 이 의료 시설들은 엑스레이, 초음파, 유방촬영 서비스를 제공하며, 총 매출 220만 달러와 EBITDA 50만 달러를 창출하고 있습니다. 이번 인수는 2025년 7월 완료될 예정이며, 규제 승인, 실사, 기관 자금 확보가 조건입니다. 또한, 회사는 2024 회계연도 말 보고서 제출이 7~10일 내로 지연될 것이라고 발표했으며, 이후 현재의 거래 중지 명령을 해제하고 TSX 벤처 거래소에서 거래 재개를 추진할 예정입니다.
La filiale de LevelJump Healthcare, CTS, a signé un accord définitif pour acquérir deux cliniques d'imagerie diagnostique à Calgary, Alberta, pour 1,92 million de dollars en espèces. Ces établissements offrent des services de radiographie, d'échographie et de mammographie, générant un chiffre d'affaires combiné de 2,2 millions de dollars et un EBITDA de 500 000 dollars. L'acquisition, dont la clôture est prévue pour juillet 2025, est soumise à l'approbation réglementaire, à la diligence raisonnable et à l'obtention d'un financement institutionnel. Par ailleurs, la société a annoncé un retard dans le dépôt de ses documents de reporting de fin d'année 2024, désormais attendu sous 7 à 10 jours, après quoi elle cherchera à lever l'ordre de suspension de négociation actuel et à rétablir la cotation sur la TSX Venture Exchange.
Die Tochtergesellschaft von LevelJump Healthcare, CTS, hat eine endgültige Vereinbarung zum Erwerb von zwei diagnostischen Bildgebungszentren in Calgary, Alberta, für 1,92 Millionen US-Dollar in bar unterzeichnet. Die Einrichtungen bieten Röntgen-, Ultraschall- und Mammographie-Dienstleistungen an und erzielen einen kombinierten Umsatz von 2,2 Millionen US-Dollar sowie ein EBITDA von 500.000 US-Dollar. Der Erwerb, der voraussichtlich im Juli 2025 abgeschlossen wird, steht unter dem Vorbehalt der behördlichen Genehmigung, der Due Diligence und der Sicherstellung der institutionellen Finanzierung. Zudem gab das Unternehmen eine Verzögerung bei der Einreichung der Jahresabschlussunterlagen 2024 bekannt, die nun innerhalb von 7-10 Tagen erwartet wird, wonach es die Aufhebung der aktuellen Handelsaussetzung anstrebt und den Handel an der TSX Venture Exchange wieder aufnehmen möchte.
Positive
  • Acquisition of two profitable diagnostic imaging clinics for $1.92M with combined revenue of $2.2M and EBITDA of $500,000
  • Transaction will be accretive and expand diagnostic services footprint in Alberta
  • Strategic expansion in Calgary healthcare market
Negative
  • Company is currently under cease trade order due to delayed financial reporting
  • Acquisition depends on securing institutional financing and regulatory approvals
  • Year-end 2024 financial reports are delayed

Toronto, Ontario--(Newsfile Corp. - June 13, 2025) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company"), is pleased to announce that its subsidiary, Canadian Teleradiology Services ("CTS"), has signed a definitive agreement to acquire two diagnostic imaging clinics, also known as independent healthcare facilities ("IHFs"), from private Alberta vendors.

The purchase price is $1.92 million cash which includes a $20,000 deposit.

The transaction is targeted to close in July 2025 and is subject to several conditions, including but not limited to, required regulatory approval, satisfactory due diligence and securing an institutional credit facility to fund the balance of the cash portion of the purchase price.

These IHFs offer medical imaging including x-ray, ultrasound, and mammography scans. The IHFs are in Calgary, Alberta.

Combined, the two IHF's are currently reporting revenue of approximately $2.2 million with EBITDA of approximately $500,000.

"This acquisition marks another important milestone for LevelJump," said Mitch Geisler, CEO of LevelJump. "The transaction will be accretive and support the continued expansion of our diagnostic services. We remain focused on growing our ADC brand and enhancing our footprint in the Alberta healthcare sector."

Update on Year End Reporting Documents

Further to its news release of April 30, 2025, the Company wishes to advise that completion and filing of its 2024 year end reporting documents has been delayed slightly and now anticipates completing and filing them in the next 7 to 10 days. Once the filings are made and the current cease trade order is revoked, the Company will be proceeding with an application to reinstate trading of its common shares on the TSX Venture Exchange.

About LevelJump Healthcare

LevelJump Healthcare Corp., (TSXV: JUMP) provides telehealth solutions to client hospitals and imaging centers through its Teleradiology division, as well as in person radiology services through its Diagnostic Centres. JUMP focuses primarily on critical care for urgent and emergency patients, establishing integral relationships in the communities we serve.

ON BEHALF OF THE BOARD OF DIRECTORS OF
LEVELJUMP HEALTHCARE CORP.

Mitchell Geisler, Chief Executive Officer
info@leveljumphealthcare.com
(833) 840-2020

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION

This news release contains "forward-looking information" within the meaning of applicable securities laws relating to the Company's business plans and the outlook of the Company's industry. Although the Company believes, in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate, that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements in this press release are made as of the date of this release and the Company assumes no responsibility to update them or revise them to reflect new events or circumstances other than as required by applicable securities laws. The Company undertakes no obligation to comment on analyses, expectations or statements made by third parties in respect of the Company, Canadian Teleradiology Services, Inc., their securities, or their respective financial or operating results (as applicable).

Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.

The securities being offered have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any U.S. state securities laws, and may not be offered or sold in the United States or to, or for the account or benefit of, United States persons absent registration or an applicable exemption from the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities in the United States, nor in any other jurisdiction.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/255450

FAQ

What is the value of LevelJump's acquisition of Alberta diagnostic imaging clinics?

LevelJump is acquiring two diagnostic imaging clinics in Calgary, Alberta for $1.92 million in cash.

What is the revenue and EBITDA of the acquired clinics by JMPHF?

The two clinics generate combined revenue of approximately $2.2 million with EBITDA of approximately $500,000.

When will LevelJump's shares resume trading on TSX Venture Exchange?

Trading will resume after the company files its 2024 year-end reports (expected in 7-10 days) and the cease trade order is revoked.

What services do the acquired Alberta clinics offer?

The clinics offer medical imaging services including x-ray, ultrasound, and mammography scans.

What conditions must be met for LevelJump's acquisition to close?

The acquisition requires regulatory approval, satisfactory due diligence, and securing an institutional credit facility for the purchase price.
Leveljump Health

OTC:JMPHF

JMPHF Rankings

JMPHF Latest News

JMPHF Stock Data

3.48M
70.84M
26.58%
Diagnostics & Research
Healthcare
Link
Canada
Toronto